Landscapes / Companies
Acepodia Biotech, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 4 in all
Trials
3 active
5 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 20 Sep 2029Phase 1/2 trial completes | |||
| Next date | 20 Sep 2029 · Phase 1/2 trial completes | ||||
| Also tested for | IgG4 Related Disease | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumor, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | May 2030Phase 1 trial completes | |||
| Next date | May 2030 · Phase 1 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Metastatic and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- ACE1702
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021